{
    "BIDSVersion": "1.6.0",
    "License": "CC0",
    "Name": "Positron emission tomography (PET) quantification in rodent of cyclooxygenase-2 (COX-2), a potential biomarker of neuroinflammation",
    "Authors": [
        "Xuefeng Yan, Martin Noergaard, Cheryl L. Morse, Jeih-San Liow, Jinsoo Hong,  Douglas Greve, Sanjay Telu, Min-Jeong Kim, Jose A. Montero Santamaria, Anthony Galassi, Ningping Feng, Sarah K. Williams Avram, Ted B. Usdin, Shawn Wu, Andrea Zhang, Lester S. Manly, Madeline Jenkins, Maia Van Buskirk, Adrian Lee, Sami S. Zoghbi, Victor W. Pike, Paolo Zanotti-Fregonara, and Robert B. Innis"
    ],
    "Acknowledgements": "We thank the Human Brain Collection Core (NIMH) for providing human brain tissue samples and Ioline Henter (NIMH) for invaluable editorial assistance.",
    "HowToAcknowledge": "Martin Norgaard",
    "Funding": [
        "ZIAMH002852",
        "ZIAMH002793"
    ],
    "DatasetDOI": "doi:10.18112/openneuro.ds005605.v1.0.0",
    "ReferencesAndLinks": [
        "1. Kenou BV, Manly LS, Rubovits SB, et al. Cyclooxygenases as potential PET imaging biomarkers to explore neuroinflammation in dementia. J Nucl Med. 2022;63:53s-59s.",
        "2.\tHoozemans JJ, Rozemuller AJ, van Haastert ES, Veerhuis R, Eikelenboom P. Cyclooxygenase-1 and -2 in the different stages of Alzheimers disease pathology. Curr Pharm Des. 2008;14:1419-1427.",
        "3.\tShrestha S, Kim MJ, Eldridge M, et al. PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study. J Neuroinflammation. 2020;17:140.",
        "4.\tYamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 1993;11:371-386.",
        "5.\tCortes-Salva MY, Shrestha S, Singh P, et al. 2-(4-Methylsulfonylphenyl)pyrimidines as prospective radioligands for imaging cyclooxygenase-2 with PET-synthesis, triage, and radiolabeling. Molecules. 2018;23:2850.",
        "6.\tKoo TK, Li MY. A guideline for selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;6:155-163.",
        "7.\tNørgaard M, Beliveau V, Ganz M, et al. A high-resolution in vivo atlas of the human brain's benzodiazepine binding site of GABA(A) receptors. Neuroimage. 2021;232:117878.",
        "8.\tGreve DN, Svarer C, Fisher PM, et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. Neuroimage. 2014;92:225-236.",
        "9.\tGreve DN, Salat DH, Bowen SL, et al. Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging. Neuroimage. 2016;132:334-343.",
        "10.\tOláh O, Németh I, Tóth-Szűki V, Bari F, Domoki F. Regional differences in the neuronal expression of cyclooxygenase-2 (COX-2) in the newborn pig brain. Acta Histochem Cytochem. 2012;45:187-192.",
        "11.\tBreder CD, Dewitt D, Kraig RP. Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol. 1995;355:296-315.",
        "12.\tYang H, Chen C. Cyclooxygenase-2 in synaptic signaling. Curr Pharm Des. 2008;14:1443-1451.",
        "13.\tSalinas CA, Searle GE, Gunn RN. The simplified reference tissue model: model assumption violations and their impact on binding potential. J Cereb Blood Flow Metab. 2015;35:304-311."
    ],
    "EthicsApprovals": [
        "Animal studies adhered strictly to the National Institute of Mental Health Animal Care and Use Committee guidelines and conformed to the Institute of Medicine’s recommendations for laboratory animal care standards. The human component received approval from the National Institutes of Health (NIH) Combined Neurosciences Institutional Review Board (protocol numbers: 19-M-0079 and 20-M-0082; ClinicalTrials.gov identifiers: NCT03912428 and NCT04396873)."
    ]
}